MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UK-05-0029613
Upform Pharmaceuticals Private Limited
Upform Pharmaceuticals Private Limited - trading in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.35 Cr
▲ 331% YoY
Net loss · FY 2024
₹4.69 Lakh
Net margin -3.5%
EBITDA · FY 2024
-₹4.4 Lakh
EBITDA margin -3.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Upform Pharmaceuticals Private Limited
Data last updated:
Upform Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 17 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC391385. Its GSTIN is 05AACCU9937D1Z8 (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Siva Kumar Appukuttan Sukesini (Managing Director) and Manish Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rz – 68 S/F Kh No – 31 & 32 Gali No – 6 Main Sagar Pur, Delhi, India – 110046.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.35 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4.69 Lakh (net margin -3.5%) and EBITDA of -₹4.4 Lakh (EBITDA margin -3.3%).
Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending.
Upform Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0029613). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24299DL2021PTC391385
Registration Number 391385
Incorporation Date 17 December 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-05-0029613
Key People
Siva Kumar Appukuttan Sukesini Managing Director Manish Kumar Director Srishti Kumar Director Recognitions & Rankings of Upform Pharmaceuticals
Contact details
Upform Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRz – 68 S/F Kh No – 31 & 32 Gali No – 6 Main Sagar Pur, Delhi, India – 110046
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Upform Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Upform Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Upform Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Upform Pharmaceuticals Private Limited, buy the company report.
Financials of Upform Pharmaceuticals Private Limited
FY 2025 filings availableUpform Pharmaceuticals Private Limited reported revenue of ₹1.35 Cr (up 331% YoY) for FY 2024.
Revenue · FY 2024
₹1.35 Cr ▲ 331%
Net loss · FY 2024
₹4.69 Lakh margin -3.5%
EBITDA · FY 2024
-₹4.4 Lakh margin -3.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 331%
EBITDA CAGR growth
1 year
▼ 381%
Revenue rose 331% in the latest year. EBITDA fell 381% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹4.4 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹4.69 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -3.3% | ||
| Net Profit Margin | -3.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Upform Pharmaceuticals Private Limited, buy the company report.
Board of directors of Upform Pharmaceuticals Private Limited
Upform Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siva Kumar Appukuttan Sukesini | Managing Director | 28 Nov 2024 | 1 Years 11 Months | Current |
| Manish Kumar | Director | 17 Dec 2021 | 4 Years 10 Months | Current |
| Srishti Kumar | Director | 17 Dec 2021 | 4 Years 10 Months | Current |
Auditor
Upform Pharmaceuticals Private Limited is audited by K B D G & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K B D G & CO | FY 2023 | 0031595N |
Shareholding
The shareholding of Upform Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Upform Pharmaceuticals Private Limited, buy the company report.
Legal cases
Upform Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by Upform Pharmaceuticals, 2 filed against it. 2 cases are pending and 1 is disposed.
Total cases
3
Filed by the company
1
Filed against the company
2
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sirmaur, Himachal Pradesh | Court case (Suit for Recovery) | Filed against the company by M/S Glimmer Healthcare | Pending |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed by the company against Shakti Enterprises | Pending |
| District court, Sirmaur, Himachal Pradesh | Civil miscellaneous application | Filed against the company by M/S Glimmer Healthcare | Disposed |
To see the full case history of Upform Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Upform Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Upform Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
Active EPFO establishments
1
GST
Upform Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCU9937D1Z8 | Uttarakhand | Active | 12 Apr 2022 |
To see the full GST registrations and return filing status of Upform Pharmaceuticals Private Limited, buy the company report.
Recent activity
Upform Pharmaceuticals Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Sanskriti Kumar ceased to be Director on 02 Jun 2025.
AGM
Upform Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Sanskriti Kumar ceased to be Director.
Filing
Upform Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Siva Kumar Appukuttan Sukesini was appointed as Managing Director.
Appointed
Manish Kumar was appointed as Director.
Appointed
Srishti Kumar was appointed as Director.
Incorporation
17 Dec 2021
Upform Pharmaceuticals Private Limited was registered on 17 Dec 2021 with Roc Delhi I & aged 4 years 10 months as per MCA records.
Frequently asked questions
Upform Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 17 December 2021 (5+ years old) and is registered under CIN U24299DL2021PTC391385.
Upform Pharmaceuticals has 3 current directors:
- Siva Kumar Appukuttan Sukesini - Managing Director
- Manish Kumar - Director
- Srishti Kumar - Director
The latest financial statements of Upform Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Upform Pharmaceuticals is 05AACCU9937D1Z8, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Upform Pharmaceuticals is U24299DL2021PTC391385. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Upform Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it. 2 are pending.
Upform Pharmaceuticals was incorporated on 17 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Sanskriti Kumar ceased to be Director on 02 Jun 2025. Siva Kumar Appukuttan Sukesini was appointed as Managing Director on 28 Nov 2024. Manish Kumar was appointed as Director on 17 Dec 2021. Upform Pharmaceuticals has 4 board changes on record in total.
Yes, Upform Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-05-0029613).
The registered office of Upform Pharmaceuticals is at Rz – 68 SF Kh No – 31 & 32 Gali No – 6 Main Sagar Pur, Delhi, India – 110046.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages